Advertisement
Screener

ODYSIGHT.AI INC. (ODYS) Spending and interest coverage

ODYSIGHT.AI INC. (ODYS) Spending and interest coverage

  • R&D / revenue · 12 months: Value 880.09%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 253.67%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months880.09%Research and development expense / revenue. Period ending 2026-06-30.

$9.59M ÷ $1.09M × 100 ≈ 880.09%

Stock-based compensation / revenue · 12 months253.67%Share-based compensation / revenue. Period ending 2026-06-30.

$2.77M ÷ $1.09M × 100 ≈ 253.67%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending9.59M USDResearch and Development Expense
Revenue1.09M USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation2.77M USDShare-based Payment Arrangement, Noncash Expense
Operating income-19.01M USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30$9.59M$1.09M$2.77M$-19.01M(m)880.09%253.67%(m)(m)
2026-03-31$9.71M$1.03M$3.16M$-18.91M(m)940.79%306.01%(m)(m)
2025-12-31$9.64M$3.02M$3.08M$-18.14M(m)319.70%102.09%(m)(m)
2025-09-30$9.50M$3.88M$3.45M$-17.47M(m)244.87%88.94%(m)(m)
2025-06-30$8.75M$5.02M$3.07M$-15.78M(m)174.24%61.20%(m)(m)
2025-03-31$7.80M$5.84M$2.69M$-13.70M(m)133.58%46.08%(m)(m)
2024-12-31$6.88M$3.96M$2.39M$-12.51M(m)173.66%60.19%(m)(m)
2024-09-30$6.20M$4.61M$2.11M$-10.61M(m)134.61%45.77%(m)(m)
2024-06-30$5.82M$3.42M$1.94M$-10.46M(m)170.09%56.72%(m)(m)
2024-03-31$5.77M$2.92M$1.82M$-11.22M(m)197.84%62.26%(m)(m)
2023-12-31$5.60M$3.03M$1.66M$-10.63M(m)184.70%54.86%(m)(m)
2023-09-30$5.28M$1.25M$778.00K$-10.53M(m)423.84%62.44%(m)(m)
2023-06-30$4.97M$1.27M$866.00K$-9.99M(m)391.73%68.19%(m)(m)
2023-03-31$4.64M$966.00K$1.21M$-9.45M(m)480.43%125.67%(m)(m)
2022-12-31$4.20M$665.00K$1.64M$-9.44M(m)631.13%246.32%(m)(m)
2022-09-30$3.83M$572.00K$2.63M$-10.53M(m)669.93%459.62%(m)(m)
2022-06-30$3.33M$461.00K$2.85M$-10.78M(m)723.21%618.66%(m)(m)
2022-03-31$2.67M$365.00K$2.72M$-10.29M(m)732.88%746.03%(m)(m)
2021-12-31$2.00M$387.00K$2.03M$-9.11M(m)517.31%524.55%(m)(m)
2021-09-30$1.56M$726.00K$1.50M$-7.48M(m)215.01%206.20%(m)(m)
2021-06-30$1.11M$715.00K$905.00K$-5.95M(m)155.10%126.57%(m)(m)
2021-03-31$803.00K$475.00K$504.00K$-4.79M(m)169.05%106.11%(m)(m)
2020-12-31$725.00K$491.00K$1.11M$-4.71M(m)147.66%225.46%(m)(m)
2020-09-30$572.00K$123.00K(m)$-4.22M(m)465.04%(m)(m)(m)
2020-06-30$503.00K$239.00K(m)$-3.58M(m)210.46%(m)(m)(m)
2020-03-31$442.00K$325.00K(m)$-2.99M(m)136.00%(m)(m)(m)
2019-12-31$274.00K$309.00K$27.00K$-1.81M(m)88.67%8.74%(m)(m)
2019-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-03-31(m)(m)(m)(m)$8.04K(m)(m)(m)Reported
2018-12-31(m)(m)(m)(m)$6.74K(m)(m)(m)Reported
2018-09-30(m)(m)(m)(m)$5.43K(m)(m)(m)Reported
2018-06-30(m)(m)(m)(m)$5.04K(m)(m)(m)Reported
2018-03-31(m)(m)(m)(m)$4.60K(m)(m)(m)Reported
2017-12-31(m)(m)(m)(m)$3.66K(m)(m)(m)Reported
2017-09-30(m)(m)(m)(m)$3.50K(m)(m)(m)Reported
2017-06-30(m)(m)(m)(m)$3.02K(m)(m)(m)Reported
2017-03-31(m)(m)(m)(m)$2.77K(m)(m)(m)Reported
2016-12-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-03-31(m)(m)(m)(m)$261.00(m)(m)(m)Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Brand Engagement Network Inc. (BNAI)United States$0.048B
STEM, INC. (STEM)United States$0.038B-1.03
CREATIVE REALITIES, INC. (CREX)United States$0.036B-2.64
CSP INC /MA/ (CSPI)United States$0.077B-117.69
Fusemachines Inc. (FUSE)United States$0.017B
Healthcare Triangle, Inc. (HCTI)United States$0.011B
Super League Enterprise, Inc. (SLE)United States$0.009B-0.20
CID Holdco, Inc. (DAIC)United States$0.103B
Algorhythm Holdings, Inc. (RIME)United States$0.003B-0.61
WIDEPOINT CORP (WYY)United States$0.109B-137.61